FrancoNevada (FNV)
(Delayed Data from NYSE)
$128.48 USD
+2.73 (2.17%)
Updated May 17, 2024 04:00 PM ET
After-Market: $128.85 +0.37 (0.29%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$128.48 USD
+2.73 (2.17%)
Updated May 17, 2024 04:00 PM ET
After-Market: $128.85 +0.37 (0.29%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Zacks News
Albemarle (ALB) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Benefits of cost-saving initiatives are expected to get reflected on Albemarle's (ALB) Q3 results.
Franco-Nevada (FNV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Franco-Nevada (FNV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BTG vs. FNV: Which Stock Is the Better Value Option?
by Zacks Equity Research
BTG vs. FNV: Which Stock Is the Better Value Option?
Why Franco-Nevada (FNV) Could Beat Earnings Estimates Again
by Zacks Equity Research
Franco-Nevada (FNV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
HMY or FNV: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
HMY vs. FNV: Which Stock Is the Better Value Option?
Franco-Nevada Up 48% in a Year: What's Driving the Rally?
by Zacks Equity Research
Franco-Nevada's (FNV) shares have been gaining on the back of consistent growth in earnings over the past few quarters and higher gold prices
HMY or FNV: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
HMY vs. FNV: Which Stock Is the Better Value Option?
Why Is Franco-Nevada (FNV) Down 5.3% Since Last Earnings Report?
by Zacks Equity Research
Franco-Nevada (FNV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
AU or FNV: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
AU vs. FNV: Which Stock Is the Better Value Option?
Franco-Nevada (FNV) Q2 Earnings Top, Revenues Miss Estimates
by Zacks Equity Research
Franco-Nevada (FNV) expects to benefit from improved mining operations, higher gold prices and stabilization in oil and gas prices in the current year.
Gold Mining Stocks' Aug 5 Earnings Roster: FNV, RGLD & More
by Madhurima Das
Gold mining stocks' performance in the June-ending quarter are likely to reflect high gold prices fueled by the coronavirus pandemic.
Franco-Nevada (FNV) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Franco-Nevada (FNV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GFI vs. FNV: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
GFI vs. FNV: Which Stock Is the Better Value Option?
AU or FNV: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
AU vs. FNV: Which Stock Is the Better Value Option?
The Zacks Analyst Blog Highlights: Novartis, Equinix, Newmont, Enterprise Products Partners and Franco-Nevada
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Novartis, Equinix, Newmont, Enterprise Products Partners and Franco-Nevada
Franco-Nevada Shares Up 32% YTD: What's Driving the Rally?
by Zacks Equity Research
Franco-Nevada's (FNV) shares have been gaining so far this year driven by solid first-quarter results and higher gold prices.
Top Analyst Reports for Novartis, Equinix & Newmont
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Novartis (NVS), Equinix (EQIX) and Newmont (NEM).
AU vs. FNV: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
AU vs. FNV: Which Stock Is the Better Value Option?
Steel Dynamics Issues Q2 View, Lower Shipments to Hurt Margin
by Zacks Equity Research
Steel Dynamics (STLD) expects steel operations to be considerably lower in Q2 due to lower shipments and selling values.
Dow (DOW) to Develop PCR Resins to Lower Carbon Footprint
by Zacks Equity Research
The offering is part of Dow's (DOW) comprehensive strategy to develop a circular plastics economy by focusing on incorporating recycled content into product offerings.
Here's Why You Should Keep Eastman Chemical in Your Portfolio
by Zacks Equity Research
Eastman Chemical (EMN) gains from innovation and cost actions amid a weak demand environment.
Univar (UNVR) Set to Distribute Wax Products of Poth Hille
by Zacks Equity Research
Univar (UNVR) expects the distribution deal to help Poth Hille to expand wax-based solutions to a broader geographical region.
Century Aluminum Prices Senior Notes Offerings Worth $250M
by Zacks Equity Research
Century Aluminum (CENX) plans to use the net proceeds for the purchase of all of its $250-million outstanding principal amount of 7.50% senior secured notes slated to mature in 2021.
Allegheny (ATI) Prices Convertible Notes Offering Due 2025
by Zacks Equity Research
Allegheny (ATI) intends to use a portion of the net proceeds from notes offering to repurchase senior notes due 2022.
U.S. Steel Sees Lower Demand to Hurt Q2 Financial Results
by Zacks Equity Research
U.S. Steel (X) anticipates second-quarter 2020 results to be significantly impacted by the coronavirus pandemic